Lasa Supergenerics
Lasa Supergenerics Performance
Day Range
- Low 26.3
- High 27.3
52 Week Range
- Low 17.1
- High 43
- Open Price26.6
- Previous Close27
- Volume33546
Start SIP in Lasa Supergenerics
Start SIPLasa Supergenerics Investment Rating
-
Master Rating:
-
Lasa Supergenerics has an operating revenue of Rs. 131.25 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of -33% needs improvement, ROE of -32% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 24 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 45 indicates it belongs to a fair industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 31 | 35 | 32 | 34 | 29 | 51 |
Operating Expenses Qtr Cr | 27 | 31 | 34 | 34 | 37 | 40 |
Operating Profit Qtr Cr | 4 | 4 | -2 | 0 | -8 | 11 |
Depreciation Qtr Cr | 3 | 4 | 3 | 3 | 3 | 3 |
Interest Qtr Cr | 0 | 0 | 0 | 1 | 0 | 0 |
Tax Qtr Cr | 6 | -4 | 0 | 0 | 1 | -1 |
Net Profit Qtr Cr | -5 | -15 | -5 | -7 | -12 | 12 |
Lasa Supergenerics Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 6
- Bearish Moving Average
- ___
- 10
- 20 Day
- ₹27.95
- 50 Day
- ₹26.57
- 100 Day
- ₹25.71
- 200 Day
- ₹27.46
- 20 Day
- ₹29
- 50 Day
- ₹25.85
- 100 Day
- ₹24.52
- 200 Day
- ₹25.64
Lasa Supergenerics Resistance and Support
Resistance | |
---|---|
First Resistance | ₹27.37 |
Second Resistance | ₹27.84 |
Third Resistance | ₹28.37 |
RSI | 45.68 |
MFI | 13.46 |
MACD Single Line | 0.83 |
MACD | 0.31 |
Support | |
---|---|
First Resistance | ₹26.37 |
Second Resistance | ₹25.84 |
Third Resistance | ₹25.37 |
Lasa Supergenerics Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 41,760 | 4,176,000 | 100 |
Week | 54,036 | 5,403,625 | 100 |
1 Month | 289,581 | 15,828,518 | 54.66 |
6 Month | 150,351 | 8,780,507 | 58.4 |
Lasa Supergenerics Result Highlights
Lasa Supergenerics Synopsis
NSE-Medical-Ethical Drugs
Lasa Supergenerics is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 129.57 Cr. and Equity Capital is Rs. 50.10 Cr. for the Year ended 31/03/2023. Lasa Supergenerics Ltd. is a Public Limited Listed company incorporated on 11/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24233MH2016PLC274202 and registration number is 274202.Market Cap | 134 |
Sales | 131 |
Shares in Float | 2.30 |
No of funds | 1 |
Yield | 1.14 |
Book Value | 1.14 |
U/D Vol ratio | 2.6 |
LTDebt / Equity | |
Alpha | -0.09 |
Beta | 0.94 |
Lasa Supergenerics
Owner Name | Jun-23 | Mar-23 | Jan-23 | Dec-22 |
---|---|---|---|---|
Promoters | 53.65% | 53.65% | 53.65% | 43.78% |
Mutual Funds | ||||
Insurance Companies | ||||
Foreign Portfolio Investors | ||||
Financial Institutions/ Banks | ||||
Individual Investors | 33.87% | 33.87% | 31.29% | 38.13% |
Others | 12.48% | 12.48% | 15.06% | 18.09% |
Lasa Supergenerics Management
Name | Designation |
---|---|
Dr. Omkar Pravin Herlekar | Chairman & Managing Director |
Mr. Shivanand G Hegde | Whole Time Director |
Mr. Hardesh Raja Tolani | Independent Director |
Ms. Ekta Avtar Gurnasinghani | Independent Director |
Mr. Ajay Hareshlal Sukhwani | Independent Director |
Ms. Manali Roop Bhagtani | Independent Director |
Lasa Supergenerics Forecast
Price Estimates
Lasa Supergenerics Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-14 | Quarterly Results | |
2023-06-07 | Audited Results | (Revised) per share(2.5%)Final Dividend |
2023-02-14 | Quarterly Results | |
2022-11-14 | Quarterly Results | |
2022-08-08 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- IndusInd Bank
- 1453
- 2.9
- Maruti Suzuki
- 10535
- 2.4
- St Bk of India
- 598
- 1.7
- M & M
- 1607
- 1.5
- Bajaj Finserv
- 1544
- 1.1
- Company Name
- CMP
- Chg(%)
Lasa Supergenerics FAQs
What is Share Price of Lasa Supergenerics ?
Lasa Supergenerics share price is ₹26 As on 22 September, 2023 | 22:46
What is the Market Cap of Lasa Supergenerics ?
The Market Cap of Lasa Supergenerics is ₹134.8 Cr As on 22 September, 2023 | 22:46
What is the P/E ratio of Lasa Supergenerics ?
The P/E ratio of Lasa Supergenerics is -4.3 As on 22 September, 2023 | 22:46
What is the PB ratio of Lasa Supergenerics ?
The PB ratio of Lasa Supergenerics is 1.1 As on 22 September, 2023 | 22:46